Cevostamab (Anti- FcRH5 / IRTA2 / CD307e)
A2746
Product group Antibodies
Overview
- SupplierSelleck Chemicals
- Product NameCevostamab (Anti- FcRH5 / IRTA2 / CD307e)
- Delivery Days Customer9
- CertificationResearch Use Only
- Estimated Purity...
- Scientific DescriptionCevostamab (Anti- FcRH5 / IRTA2 / CD307e) is a humanized IgG1-based bispecific antibody that targets membrane-proximal extracellular domain of FcRH5 on multiple myeloma (MM) cells as well as CD3 on T cells. MW: 145.24 kD.
- Storage Instruction-20°C
- UNSPSC12352203